About

Center for Medical Biotechnology

CMB in a nutshell

Science director: Nico Callewaert

At CMB, the focus lies on the development of new and innovative molecular tools and technologies to address human health problems. An emerging and fascinating research theme is the development and production of new biopharmaceuticals and vaccines. CMB researchers are working on new applications in tuberculosis research, cancer treatment and antiviral immunity, among others. Research at CMB pushes the boundaries of biomolecular/bioinformatics research and engineering. We also translate our new technologies and insights into widely applicable research tools, vaccines, diagnostics and pharmaceuticals.

News

Labs

Function
VIB Group Leader / Expert
Extra info
VIB-UGent Center for Medical Biotechnology
Function
VIB Group Leader / Expert
Extra info
VIB-UGent Center for Medical Biotechnology
Function
VIB Group Leader / Expert
Extra info
VIB-UGent Center for Medical Biotechnology
Function
VIB Group Leader / Expert
Extra info
VIB-UGent Center for Medical Biotechnology
Function
VIB Group Leader / Expert
Extra info
VIB-UGent Center for Medical Biotechnology
Function
VIB Group Leader / Expert
Extra info
VIB-UGent Center for Medical Biotechnology
Function
VIB Group Leader / Expert
Extra info
VIB-UGent Center for Medical Biotechnology
Function
VIB Group Leader / Expert
Extra info
VIB-UGent Center for Medical Biotechnology

Impact on society

Blood test for liver diseases

Blood test for liver diseases

VIB, in collaboration with Helena Biosciences, is set to commercialize a comprehensive blood test called Glyco Liver Profile for chronic liver diseases, a condition affecting up to 29 million people in the EU. This non-invasive test allows medical professionals to diagnose and monitor liver inflammation, fibrosis, and cirrhosis, providing an accurate and personalized alternative to invasive techniques.
Read more

Start ups